Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-20-001370

Chief Scientific Officer sold 622 shares at $26.95 ($16,763)

  • Chief Scientific Officer acquired 11,593 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Albright Charles · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-06 Grant or award : show line 1 in the form +11,593 32,146 D
2020-02-07 Sale : show line 2 in the form −622 $26.95 $16,763 31,524 D
Open-market sales · 622 sh · avg $26.95 · $16,763

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-06 Grant or award : show line 3 in the form Stock Option (right to buy) +69,556 69,556 D
Loading xslF345X03/edgar.xml…